
Pipeline Database
UB842
Omeprazole and Sodium Bicarbonate Capsules
UB842
ProductOmeprazole and Sodium Bicarbonate Capsules
StrengthEach capsule contains omeprazole 20mg and sodium bicarbonate 1100mg
IndicationsGastric ulcer; Duodenal ulcer; Gastrooesophageal reflux disease; Zollinger-Ellison syndrome
TherapeuticsGastroenterology & Hepatology
GMPCN - NMPA
RegistrationChina
ModalitiesSmall Molecule
Exclusive Summary
- Differentiated Immediate-Release Profile: The addition of sodium bicarbonate enables rapid omeprazole absorption, providing significantly faster relief than traditional delayed-release capsules and controlling nocturnal acid breakthrough.
- Favorable Competitive Landscape: Unlike the heavily saturated plain omeprazole market, this combination has higher formulation barriers and fewer generic competitors, protecting distributors from severe price wars.
- Massive Market Demand: Driven by a global GERD prevalence of 13-19% and hundreds of millions of patients reliably continuously demanding highly effective PPI therapies.
- Overwhelming Cost Advantage: Leveraging China's vertically integrated API-formulation supply chain ensures highly competitive pricing, guaranteeing lucrative profit margins for overseas distributors.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →